2025
SJR Q1
JCR Q1 · 8,2
89 matched articles
SCIE
Journal detail
Archives of Pharmacal Research
- Publisher
- Pharmaceutical Society of Korea
- Country
- South Korea · Asiatic Region
- Type
- journal
- ISSN
-
0253626919763786
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 1,84
- Quartile Q1
- H-Index 118
- Cites/doc 8,64
- Docs (3y) 156
- Cites (3y) 1.440
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 8,2
- 5Y JIF 8
- JCI 1,37
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Drug Discovery Q1
- Molecular Medicine Q1
- Organic Chemistry Q1
Areas
- Biochemistry, Genetics and Molecular Biology
- Chemistry
- Pharmacology, Toxicology and Pharmaceutics
WoS categories
- Chemistry, Medicinal | Pharmacology & Pharmacy
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 1,84 | 8,2 | 8 | 1,37 | Q1 | 118 |
| 2024 | Q1 | Q1 | 1,87 | 7,5 | 6,7 | 1,37 | Q1 | 112 |
| 2023 | Q1 | Q1 | 1,481 | 6,9 | 5,7 | 1,26 | Q1 | 112 |
| 2022 | Q1 | Q1 | 1,163 | 6,7 | 5,2 | 1,13 | Q1 | 112 |
| 2021 | Q1 | Q1 | 0,93 | 6 | 4,3 | 1,04 | Q1 | 112 |
| 2020 | Q1 | Q1 | 0,855 | 4,9 | 3,5 | 0,94 | Q2 | 112 |
| 2019 | Q2 | Q2 | 0,675 | 2,9 | 2,5 | 0,85 | Q2 | 112 |
| 2018 | — | Q3 | — | 2,5 | 2,5 | 0,75 | Q2 | — |
| 2017 | Q2 | Q3 | 0,626 | 2,3 | 2,2 | 0,74 | Q2 | 112 |
| 2016 | Q2 | Q3 | 0,661 | 2,2 | 2,1 | — | — | 112 |
| 2015 | Q2 | Q2 | 0,658 | 2,5 | 2,2 | — | — | 112 |
| 2014 | Q2 | Q3 | 0,664 | 2 | 2 | — | — | 112 |
| 2013 | Q2 | Q3 | 0,561 | 1,8 | 1,9 | — | — | 112 |
| 2012 | Q2 | Q3 | 0,572 | 1,5 | 1,7 | — | — | 112 |
| 2011 | Q2 | Q3 | 0,56 | 1,6 | 1,6 | — | — | 112 |
| 2010 | Q2 | Q3 | 0,558 | 1,6 | 1,6 | — | — | 112 |
| 2009 | — | Q3 | — | 1,2 | 1,3 | — | — | — |
| 2008 | — | Q4 | — | 1,1 | 1,2 | — | — | — |
| 2007 | — | Q3 | — | 1,1 | 1,1 | — | — | — |
| 2006 | — | Q3 | — | 0,9 | — | — | — | — |
| 2005 | — | Q4 | — | 0,8 | — | — | — | — |
| 2004 | — | Q4 | — | 0,7 | — | — | — | — |
| 2003 | — | Q4 | — | 0,6 | — | — | — | — |
| 2002 | — | Q4 | — | 0,7 | — | — | — | — |
| 2001 | — | Q4 | — | 0,7 | — | — | — | — |
| 2000 | — | Q4 | — | 0,6 | — | — | — | — |
| 1999 | — | Q4 | — | 0,4 | — | — | — | — |
| 1998 | — | Q4 | — | 0,3 | — | — | — | — |
| 1997 | — | Q4 | — | 0,3 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | CHEMISTRY, MEDICINAL | SCIE | Q1 | Q1 | 5/72 |
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 20/356 |
| 2024 | CHEMISTRY, MEDICINAL | SCIE | Q1 | Q1 | 5/72 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 19/352 |
| 2023 | CHEMISTRY, MEDICINAL | SCIE | Q1 | Q1 | 3/72 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 15/354 |
| 2022 | CHEMISTRY, MEDICINAL | SCIE | Q1 | Q1 | 7/60 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 28/278 |
| 2021 | CHEMISTRY, MEDICINAL | SCIE | Q1 | Q2 | 11/63 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 49/279 |
| 2020 | CHEMISTRY, MEDICINAL | SCIE | Q2 | Q2 | 16/62 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q2 | 68/276 |
| 2019 | CHEMISTRY, MEDICINAL | SCIE | Q2 | Q2 | 28/61 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 117/271 |
| 2018 | CHEMISTRY, MEDICINAL | SCIE | Q3 | Q2 | 32/61 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 141/267 |
| 2017 | CHEMISTRY, MEDICINAL | SCIE | Q3 | Q2 | 36/59 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 144/261 |
| 2016 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 37/60 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 143/257 |
| 2015 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 30/59 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 113/255 |
| 2014 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 35/59 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 145/255 |
| 2013 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 38/58 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 164/256 |
| 2012 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 43/59 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 180/261 |
| 2011 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 38/59 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 174/261 |
| 2010 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 28/54 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 172/252 |
| 2009 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 33/46 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 186/237 |
| 2008 | CHEMISTRY, MEDICINAL | SCIE | Q4 | — | 31/41 |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 175/219 |
| 2007 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 30/41 |
| 2007 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 160/205 |
| 2006 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 26/35 |
| 2006 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 161/199 |
| 2005 | CHEMISTRY, MEDICINAL | SCIE | Q4 | — | 28/34 |
| 2005 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 162/193 |
| 2004 | CHEMISTRY, MEDICINAL | SCIE | Q4 | — | 29/36 |
| 2004 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 158/187 |
| 2003 | CHEMISTRY, MEDICINAL | SCIE | Q4 | — | 34/37 |
| 2003 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 167/185 |
| 2002 | CHEMISTRY, MEDICINAL | SCIE | Q4 | — | 30/35 |
| 2002 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 149/188 |
| 2001 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q4 | — | 262/308 |
| 2001 | CHEMISTRY, MEDICINAL | SCIE | Q4 | — | 30/36 |
| 2001 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 146/186 |
| 2000 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q4 | — | 268/310 |
| 2000 | CHEMISTRY, MEDICINAL | SCIE | Q4 | — | 28/35 |
| 2000 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 146/181 |
| 1999 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q4 | — | 274/295 |
| 1999 | CHEMISTRY, MEDICINAL | SCIE | Q4 | — | 28/30 |
| 1999 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 161/175 |
| 1998 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q4 | — | 272/295 |
| 1998 | CHEMISTRY, MEDICINAL | SCIE | Q4 | — | 29/30 |
| 1998 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 159/178 |
| 1997 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q4 | — | 246/253 |
| 1997 | CHEMISTRY, MEDICINAL | SCIE | Q4 | — | 27/28 |
| 1997 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 152/157 |